![]() |
市场调查报告书
商品编码
2020217
腹腔镜手术器械市场规模、份额、成长及全球产业分析:按类型、应用和地区分類的洞察,2026-2034年预测Laparoscopy Instruments Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球腹腔镜手术器械市场规模为178.6亿美元,预计2026年将成长至194亿美元,到2034年将达到411.2亿美元,预测期内复合年增长率为9.84%。 2025年,北美市场占据主导地位,市占率达50.66%,主要得益于微创手术技术的高普及率以及主要企业的强大市场地位。
腹腔镜手术,俗称“微创手术”,是一种微创外科技术,使外科医生能够通过腹部和骨盆内的微小切口进行手术。腹腔镜设备市场主要包括能量器材和内视镜器械。能量器械,例如超音波和射频器械,有助于有效切割组织;而内视镜器械则用于组织操作、器官取出和固定等手术。
市场成长要素
外科医生和患者对腹腔镜手术日益增长的偏好是推动市场成长的主要因素之一。微创手术具有许多优势,包括减少疤痕、缩短恢復时间、降低感染风险和减少住院时间。此外,胆结石、阑尾炎和疝气等疾病在全球的发生率不断上升,也进一步刺激了对腹腔镜器械的需求。
2020年,新冠感染疾病导致手术延期,暂时降低了市场需求。然而,随着手术数量的增加,市场在2021年和2022年復苏,预计这一稳定上升的趋势将持续到2034年。
技术创新也在推动市场扩张。例如,手部辅助腹腔镜手术(HALS)的引入简化了切除术等复杂手术,其应用日益广泛。根据韩国癌症协会的数据,腹腔镜大肠直肠癌手术的比例从2013年的64.9%上升到2018年的78.5%,同期直肠癌手术的比例也从65.4%上升到81.6%。
市场区隔
按类型划分:能源设备细分市场规模最大,预计到2025年将占市场份额的29.28%。其子类别包括产生器、血管封闭器和其他电外科器械。技术的不断进步和对医疗设备采购日益增长的关注是推动该细分市场成长的主要因素。
按应用领域划分:一次性腹腔镜器械因其安全性、便利性和低污染风险而占据市场主导地位,预计到 2025 年将占据 62.47% 的市场份额。它们消除了消毒难题,并且越来越受到人们的青睐,超过了可重复使用的器械。
按应用领域划分,包括盲肠切除手术、胆囊切除术、疝气修补术和减肥手术在内的普通外科手术占比最大(预计到2025年将达到47.75%),并且预计将持续增长。急性阑尾炎和胆结石病例的增加是推动这一趋势的主要因素。例如,根据经合组织的数据,2020年法国所有盲肠切除手术中,腹腔镜盲肠切除手术占88.4%。
按最终用户划分:预计到 2026 年,医院和门诊手术中心将占据主导地位,占市场份额的 79.00%。这是因为病患数量庞大,人们对医院普遍信任,进而推动了医疗设备的普及。
北美:预计2025年市场规模为90.5亿美元,2026年将达98亿美元。市场成长主要受手术量增加、微创手术需求成长以及Medtronic、BD和Ethicon等主要企业的强大市场地位所驱动。在美国,90%的胆囊切除术采用腹腔镜手术,此技术已成为黄金标准。
亚太地区:预计该地区2025年市场规模将达到30.3亿美元,到2026年将增长至33.2亿美元,主要驱动因素是疾病患病率上升以及腹腔镜手术作为传统开放性手术的替代方案日益普及。在澳洲等国家,腹腔镜腹股沟疝气修补术的比例已从2010年的31.7%上升至2019年的46.8%。
欧洲和日本:腹腔镜手术在结直肠外科、一般外科和妇科手术中的应用日益广泛,加上手术器械技术的不断创新,支撑着市场的稳定成长。
主要市场参与者
全球市场由ETHICON(强生服务公司)、美敦力、Olympus Corporation、BD、康美和史赛克等主要企业主导。 ETHICON凭藉其强大的产品系列和广泛的内视镜手术器械销售网络,占据最大的市场份额。Olympus Corporation也透过POWERSEAL等产品持续巩固其市场地位,POWERSEAL可用于开放性手术手术和腹腔镜手术。
近期发展包括旨在加强腹腔镜手术相关产品和扩大产品线的收购:
市场挑战
儘管腹腔镜手术发展迅速,但仍存在一些市场限制。这些因素包括腹腔镜手术相关的併发症,例如侧向热扩散、手术烟雾风险以及套管针相关损伤。此外,在开发中国家,由于费用的考虑,患者往往更倾向于选择开放性手术而非微创手术。
成长率:2026年至2034年的复合年增长率为9.84%。
The global laparoscopy instruments market was valued at USD 17.86 billion in 2025 and is projected to grow to USD 19.40 billion in 2026, reaching USD 41.12 billion by 2034, reflecting a CAGR of 9.84% over the forecast period. North America dominated the market in 2025 with a 50.66% share, driven by the high adoption of minimally invasive surgical techniques and strong presence of key players.
Laparoscopy, commonly known as keyhole surgery, is a minimally invasive surgical approach that allows surgeons to operate inside the abdomen and pelvis through small incisions. The market for laparoscopic devices primarily includes energy devices and endomechanical instruments. Energy devices, such as ultrasonic and high-frequency instruments, assist in cutting tissue efficiently, while endomechanical instruments are used for tissue manipulation, organ removal, and attachment procedures.
Market Growth Drivers
The increasing preference for laparoscopic procedures among both surgeons and patients is one of the major factors driving market growth. Minimally invasive procedures offer numerous benefits, including reduced scarring, shorter recovery times, lower risk of infection, and minimal hospital stays. Additionally, the rising global prevalence of conditions such as gallstones, appendicitis, and hernia has further boosted the demand for laparoscopic instruments.
The COVID-19 pandemic in 2020 caused a temporary decline in demand due to postponed elective surgeries. However, the market rebounded in 2021 and 2022 as surgical volumes increased, leading to a steady upward growth trajectory expected through 2034.
Technological innovations are also propelling market expansion. For instance, the introduction of Hand-assisted Laparoscopic Surgery (HALS) has simplified complex procedures like colectomy, increasing their adoption. Data from the Korean Cancer Association shows that laparoscopic colon cancer surgeries rose from 64.9% in 2013 to 78.5% in 2018, while rectal cancer procedures increased from 65.4% to 81.6% during the same period.
Market Segmentation
By Type: The energy devices segment is the largest, accounting for 29.28% of the market in 2025. Subcategories include generators, vessel sealers, and other electrosurgical tools. Continuous technological advancement and increased focus on capital equipment procurement are driving this segment.
By Usage: Disposable laparoscopic instruments dominate the market, with a 62.47% share in 2025, due to their safety, convenience, and low risk of contamination. They eliminate sterilization challenges and are increasingly preferred over reusable instruments.
By Application: General surgery, including appendectomy, cholecystectomy, hernia repair, and bariatric surgery, accounts for the highest share (47.75% in 2025) and is expected to grow steadily. Rising cases of acute appendicitis and gallstones contribute significantly to this trend. For example, OECD data shows laparoscopic appendectomies in France accounted for 88.4% of total appendectomy procedures in 2020.
By End-user: Hospitals and ambulatory surgical centers dominate with 79.00% market share in 2026, as large patient volumes and widespread trust in hospitals drive instrument adoption.
North America: Valued at USD 9.05 billion in 2025, the region is projected to reach USD 9.8 billion in 2026. Market growth is fueled by increasing surgical procedures, preference for minimally invasive techniques, and strong presence of major companies such as Medtronic, BD, and ETHICON. In the U.S., 90% of cholecystectomies are performed laparoscopically, establishing the method as the gold standard.
Asia Pacific: The region accounted for USD 3.03 billion in 2025, projected to grow to USD 3.32 billion in 2026, due to rising disease prevalence and increasing adoption of laparoscopic surgery over traditional open surgery. Countries like Australia have seen the laparoscopic repair of inguinal hernia rise from 31.7% in 2010 to 46.8% in 2019.
Europe and Japan: Increasing adoption of laparoscopic procedures for colorectal, general, and gynecological surgeries, coupled with strong technological innovation in instruments, supports steady market growth.
Key Market Players
The global market is consolidated with major companies including ETHICON (Johnson & Johnson Services, Inc.), Medtronic, Olympus Corporation, BD, CONMED, Stryker, and others. ETHICON holds the largest share due to its strong portfolio of endomechanical surgical instruments and extensive distribution network. Olympus Corporation has also strengthened its market presence with products like POWERSEAL devices, used in both open and laparoscopic surgeries.
Recent developments include acquisitions and product expansions aimed at enhancing laparoscopic offerings:
Market Challenges
Despite its growth, the market faces restraints, including complications associated with laparoscopic procedures such as lateral thermal spread, surgical smoke hazards, and trocar-related injuries. Additionally, in developing countries, cost considerations lead patients to prefer open surgeries over minimally invasive techniques.
Conclusion
The laparoscopy instruments market is poised for strong growth through 2034, driven by increasing demand for minimally invasive procedures, technological innovations, rising disease burden, and expanding healthcare infrastructure. With a projected market size of USD 41.12 billion by 2034, North America and Asia Pacific are expected to remain key contributors, while the ongoing adoption of energy devices and disposable instruments will continue to shape the market dynamics.
Growth Rate CAGR of 9.84% from 2026-2034
Segmentation By Type
By Usage
By Application
By End-user
By Region